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Abstract 
A total of 126 mice were used to study drug resistance on 13 isolates of 
Trypanosoma evansi collected from Butana, Gadarif and Southern Kordofan 
state against Quinapyramine sulphate and Cymelarsan. For Quinapyramine 
sulphate 36 mice (6 control and 6 tested group for each state) were used (the 
drug was given S/C), the results revealed that the isolates were very sensitive 
in Southern Kordofan state (6 mice were cured), however, the isolates 
showed resistance to the drug in all mice (12 mice) infected  with T. evansi 
in Butana and Gadarif state. Regarding Cymelarsan 36 mice (6 control and 6 
tested group for each state) were used (the drug was given S/C), the results 
showed that the isolates were very sensitive in Southern Kordofan and 
Gadarif state ( all mice were cured), but the isolates showed some degree of 
resistance in Butana (4 out of 6 isolates were cured).  
 
Quinapyramine sulphate killed 18 mice infected with T. evansi (6 mice for 
each state) when the drug was given intapretoneal. Double dose was used for 
assessing drug resistance against Quinapyramine on 36 mice (6 control and 6 
tested group for each state) infected with T. evansi from Butana, Gadarif and 
Southern Kordofan state, the result revealed that 18 mice (6 mice for each 
state) were died. 
 Polymerase Chain Reaction (PCR) was used on 13 isolates of T. evansi  
from Butana, Gadarif and Southern Kordofan state, the result showed that 
PCR was very sensitive in  
detecting differences in Butana and Gadarif state all isolates were similar. 
The isolates which tested by PCR in Butana and Gadarif states, 9 of them 
were resistant to Quinapyramine sulphate and 7 isolates were sensitive to 
Cymelarsan. One isolate out of 4 isolates tested by PCR in Southern 
Kordofan state was different (the isolate was sensitive to both 
Quinapyramine sulphate and Cymelarsan.  
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
There are two types of camels in the world, the one humped camel (Camelus 
dromedarius) and the bacterian two humped camel (Camelus bacterianus). 
The bacterian camel is mainly found in the temperate regions of the 
European Russian continent. While the dromedary camel is most dominant 
and widely distributed in the tropics and sup tropics of the African and Asian 
continents. In Africa dromedary the camel dominates particularly in arid and 
semi-arid lowlands of Eastern Africa (FAO, 1997). Sudan comes after 
Somalia regarding camel population with an estimate of 3,000,000 camels. 
Under the pastoral production system of Sudan, Trypanosomiasis is one of 
the major diseases affecting camels, caused mainly by Trypanosoma evansi 
and transmitted mechanically predominatly by Tabanus species and other 
biting flies. The disease generally takes a chronic form where huge 
production losses occur due to lowered milk and meat production in adults, 
abortion, and mortalities in young camel calves (Schwartz and Dioli, 1992).  
Consumption of livestock products increases 2-3 times more in developing 
countries compared to developed countries. This is attributed to the high 
population growth and an increasing urbanization (FAO, 1992). The FAO 
report indicated that the food supply must be improved, particularly in 
naturally or artificially stressful environments due to desert creeping or man 
made disasters. Camels play major roles in improving the socio-economic 
status and survival of the desert dwellers and secure substantial sources of 
protein and energy for them. This due to anatomical and physiological 
characteristic of the camel.  Moreover, Schwartz and Dioli (1992) recorded 
that the camel milk contains the necessary protein, sugars, fats, and vitamins 
for the young calves and is valuable for the people, as a rich source of 
vitamin C in the desert where it is difficult to get it from other sources. 
The management of African trypanosomiasis at the farmer level has been  
predominately dependent on the use of trypanocidal drugs, it was estimated 
that about 35 million doses per year were used in Africa to cure the disease 
(Geerts and Holmes, 1997). Many drugs are continuously used for treatment 
of trypanosomiasis: Isometamidium, Suramin, Diminazine aceturate, 
Quinapyramine and Ethidium (Leach and Roberts, 1981) and Cymelarsan, 
which was developed in 1980 (Luckins, 1999). Despite the fact that 
chemotherapy is the major means of disease control , development of new 
anti-trypanosomal drugs have been more or less static over several years, 
due to lack of interest by the pharmaceutical industry to invest into research 
and development of anti-trypanosomal drugs (Gutteridge, 1985). 
Consequently, this has been a major stimulus to intensive research into the 
few existing drugs (Bourdichon and Zhang, 1999). 
 Drug resistance emerged as one of the major obstacles for the control of 
trypanosomiasis. It can be defined as the ability of a trypanosome strain to 
survive, despite the administration of a trypanocide given in doses equal to 
or higher than those usually recommended. Therefore, this study is planned 
to: 
 
1. Determine the extent of drug resistance of some Sudanese isolates 
of Trypanosoma evansi from Butana, Gadarif and Kordofan State 
against Quinapyramine sulphate and Cymelarsan drugs using an 
in-vivo method. 
2. Study the DNA profile of some isolates to demonstrate possible 
differences between resistant and sensitive isolates. 
 
 
 
 
 
 
 
CHAPTER ONE 
LITERATURE REVIEW 
1.1 Agro-ecological zones of Sudan 
Abdalla and Abdel Nour (2001) recorded several agro-ecological zones of 
Sudan as following: 
 
1. Arid zone: Covers 29% of the total area of the country, rain fall is 
rare, and hence there is no vegetation cover; crop production is 
concentrated in the irrigated areas along the Nile. This part of 
country falls within the water-bearing Nubian sand stone aquifer. 
2. Semi-arid zone: Comprises 20% of the total country area, rainfall 
varies from 50 to 300 mm, adequate only for annual vegetation 
suitable for limited transhumant grazing, vulnerable to frequent 
droughts, investment potential lies in rational grazing and cropping 
in valleys. 
3. Savanah- low rainfall: comprises 13%of the total area dominated 
by goz soils, and rainfall ranging from 200-400 mm, suitable for 
traditional farming sorghum, groundnuts, and millet, potential for 
farming gum Arabic and livestock.  
4. Savanah- medium rainfall: Covers 14% of the total area, rainfall 
400-800 mm, includes rain fed mechanized farming in clay soils, 
traditional farming, gum Arabic, and large summer grazing area. 
Vast agricultural potential for mechanized and improved 
traditional framing and livestock.  
5. Savanah- high rainfall: Comprises 13% of the total country area, 
includes vast pasture areas and productive soils for several crops 
with immense potential for crop production and forest. 
6. Mountainous areas: includes J. Marra, Amatong, Aloun plateaus, 
suitable for growing of tea, coffee, and other tropical crops. 
 
1.2 Distribution and utilization of the camel 
 
The dromedary or one-humped camel (Camelus dromedarius) is the 
one of two species within the genus camelus, the other being the bacterian or 
two-humped camel (Camelus bacterianus). The dromedary is originally a 
tropical animal, however, some dromedary keeping countries are located 
outside the tropics. It has been supposed that the dromedary was first 
domesticated in Southern Arabia, by people who had no other domestic 
animals to use milk for production, and then it spread to North Africa. These 
animals were also found in South America, Western Asia, India, Canary 
Islands, Caribbean and South Spain (Knoess, 1977). 
 
In pastoral production system of East Africa, camels produce milk, meat, 
blood, hair, and hide. They are also used for riding , draught purposes, and 
as pack animals (Knoess, 1977; Schwartz and Dioli, 1992). On the other 
hand camels serve as investment, provide employment and cash income 
generation. Furthermore, only in recent years there have been attempts to 
market camel milk. For instance, camel milk is now being marketed in an 
industrial manner in Saudi Arabia, and on small scale in Mauritania, 
Somalia, and in a limited scale in the Northern Kenya. It is also started to be 
sold as a health food in Europe (Schwartz and Dioli, 1992,  Köhler- 
Rollefson, 1993). 
1.3 Adaptation and feeding of the camel  
According to Schwartz and Dioli (1992), the camels are well adopted to the 
arid and extremely arid zone. This is due to the fact that the camels can 
change their body temperature to as low as 34 °C and as high as 41°C and 
produce small amounts of urine which is highly concentrated. Camels have 
the ability for water conservation using physiological mechanisms and also 
possesses behavioral and anatomical adaptation. Camels have excellent feed 
conversion efficiencies such that they convert the scattered vegetation of the 
desert into  highly nutritious food and other forms of energy as well as can 
eat bushes and branches of trees or graze on grass. Moreover, they can fed 
like cattle and eat straw, hay, silage, grains and cakes. They can eat sharp, 
thorny plants, which other animal can not eat. In dry season camel can live 
on hump fat and survive in this way for long period (Schwartz and Dioli 
,1992). 
1.4 Constraints for livestock production in Sudan 
 
Sudan has the largest animal population in East Africa. This population 
included cattle, sheep, goat, and camel. The open system or pastoral 
production system dominates depending on rainfall, while, intensive 
production system is limited and practised only around urban setups.  
 
The major constrains for livestock production system of the country include 
fodder shortages, overgrazing, and desertification, low genetic potential of 
local breeds for high production, in addition to some institutional, 
technological , and disease constraints (Abdalla and Abdel Nour, 2001). 
 
1.5 Important camel diseases 
 Scwartz and Dioli (1992) stated that the camel pox is one of the most 
important viral diseases in East Africa. The other viral diseases being 
contagious ecthyma (Para pox cameli) and camel papillomatosis. The same 
authors also explained that rabies is one of the most important zoonotic viral 
diseases which is widespread throughout Africa. 
 
On the other hand, Abraham et al (2005) demonstrated that sero-prevalence 
of peste des petits ruminants (PPR) was 3% in camels. This was 
demonstrated during his survey of antibody sero-prevalence against PPR 
virus in camels, cattle, goats, and sheep in Ethiopia. A case of an enteric 
coronavirsus infection in a 6 week-old dromedary calf was described by  
Wunschmann et al. (2002).  
 
A survey of antibodies against various infectious disease agents in racing 
camels in Abu Dhabi, in United Arab Emirates (Afzal and Sakkir, 
1994).revealed the following sero-prevalnce: Q fever (7.9%), parainfluenza 
virus type 3 (5.6%), Echinococcus polymorphus (2.6%) and toxoplasma 
gondii (36.4%), as determined by direct agglutination and indirect 
haemagglutination, respectively. Another survey regarding important camel 
disease in Turkana District in Kenya using participatory methods (Mochabo 
et al 2005) showed trypanosomiasis (11.4%), manage (10.8%), tick 
infestation (7.9%),haemorrhagic septicaemia (7.7%), and non-specific 
diarrhoea (7.6%). The same report indicated that the annual incidence and 
mortality rates of trypanosomiasis were estimated at 15% and 9.9%, in adult 
camels and 6.9% and 5.2% in young camels, respectively. 
 
Other camel diseases reported from different parts of Asia and East Africa 
included: Brucellosis in Sudan (Agab et al., 1994; ElAnsry et al., 2001), 
Foot and Mouth Disease (FMD) in united Arab Emarites (Wernery and 
Kaaden, 2004), Salmonellosis in Eastern Ethiopia (Molla et . al., 2004),  
Tetanus in united Arab Emirates (Wernery et al., 2004), and camel mastitis 
in Egypt, Saudi Arabia, Somalia, and Iraq (Karmy, 1990; Hafez et al., 1987; 
Abdurahman et al, 1991; and Al-Ani and Al Shareefi, 1997). Furthermore, 
Schwartz and Dioli (1992) recorded some other diseases observed in East 
Africa such as contagious ecthyma, Neonatal calf diarrhoea, coccidian spp. 
infection, clostridium perfringenes infection, Mycobacterium para 
tuberculosis infection , pneumonia, stiff neck, and wry neck syndrome. 
 
1.6 Camel trypanosomiasis 
 Through out  Africa typanosomiasis caused mostly by trypanosoma brucei 
evansi infection is the major protozoal disease affecting camels, the disease 
is known in North Africa as surra and in Sudan as Guffar. In the pastoral 
production system of Sudan, the disease generally takes a chronic form and 
it has a great economic impact resulting in losses in milk and meat 
production, abortion and mortalities in young camel calves (Schwartz and 
Dioli, 1992) . 
 
 
 
1.7 Morphology and taxonomy of Trypanosoma evansi 
 
According to FAO (1998), tryanosomes are unicellular organisms (phylum 
protozoa) belonging to the genus Trypanosoma, the family trypanosomatidae 
and the order Kinetoplastida. Trypannosoma evansi belongs to the subgenus 
Trypanozoon and to the brucei group.  
 
Trypanosomes are microscopic elongated unicellular flagellates. They movie 
with the help of a single flagellum. The flagellar pocket is situated near the 
kinetoplast, at the posterior end of the cell. They multiply in the body fluids, 
and especially blood stream and tissue fluids, of the vertebrate host (Itard, 
1981). 
 
 
1.8 The epidemiology and distribution of Trypanosoma evansi 
 
Trypanosoma evansi is the cause of the most important disease of camels, 
and is also highly pathogenic for equidi (horses, mules and donkeys) and  for  
dogs. It  is  also  of  considerable  economic importance in Asian domestic 
buffalo, and to a less extent in some countries in cattle as well (FAO, 1998). 
A rare case of human trypanosomiasis caused by Trypanosoma evansi in 
India was reported in adult male who used to practice veterinary medicine 
(Powar et al., 2006). 
 
Based on FAO (1998), the epidemiology of non testse-transmitted 
trypanosomiasis (Trypanosoma evansi) is influenced by seasonal outbreaks 
where the population of biting flies (tabanids, stable flies, etc) increses. The 
chronic disease sometimes becomes more clinically apparent during the dry 
season, when immunodepressive factors occur such as poor nutritional state. 
The same reference explained that T. evansi has been spread widely in 
Africa and outside in tropical and sub-tropical areas of Africa North of the 
equator, in Asia, and in South and Central America from Panama to 
Argentina. 
 
In Sudan it is prevalent in the arid and semi-arid zones in North Kordofan, 
Darfour, Kassala, Blue Nile, White Nile and Nuba mountains (El-Karib, 
1961). Prevalence of camel trypanosomiasis was studied by El Rayah 
(1997). in a belt covering Wastern, Central and Eastern Sudan. The result 
revealed that prevalence was 13.3% in the Western, 5.1% in the Central, and 
8.3% in Eastern Sudan. Another study in the epidemiology of camel 
trypanosomiasis in Kordofan States by Ibtisam (2004) indicated that the 
prevalence of camel trypanosomiasis was 11% using wet mount, blood film, 
and microhematocrit technique (MHCT). While, card Agglutination Test for 
T. evansi (CATT) gave a prevalence of 44%. 
 
1.9 Transmission of camel trypanosomiasis 
 
Trypanosoma evansi infection of camels  has been reported to be transmitted 
solely mechanically by haematophage biting flies such as familyTabanidae 
(Alylotus, Aneala, Haematopia and Tabanus) (Gruvel and Balis, 1965) 
Stomoxy and Lyprosia (Scot, 1973). Ticks are suspected but the evidence of 
their role in transmission is insufficient (Lewis, 1978). Nasal and conjuctival 
routes were also reported by Higgins (1986). Khasanov and Ivansitskaya 
(1974) explained that sheep and goats are suggested as a reservoir for T. 
evansi, they carried symptomless chronic infections of T. evansi. 
 
On the other hand, FAO (1998) report explained that trypanosomiasis can be 
transmitted by iatrogenic means. This can occur when using the same needle 
or surgical instrument on more than one animal, at sufficiently short 
intervals that the blood on the needle or instrument does not dry. The same 
report stated that the transmission of T. evansi in Latin America by the bites 
of vampire bats is  common. 
1.10 Clinical manifestations of camel trypanosomiasis 
 
Trypanosoma evansi infection in camels is characterized by  anaemia, 
emaciation and eventually death after a long course of 1-4 years.The disease 
is usually a chronic wasting disease and is difficult to detect parasites in the 
blood by direct means.(FAO, 1998).   
 
Striking clinical symptoms develop a month or so after infection, with acute 
bouts of fever, associated with dullness, lack of appetite and lachrymation 
coinciding with peaks of high parasitaemia. Oedemas may occur and 
pregranant animals often abort. (FAO, 1998). Darosa (2000) stated that the 
urine odour change detected more cases than the parasitological method 
when it was carried at the natural habitat of camels. The same author 
explained that the feeding system and the ground for urination may affect 
the application of the method.    
 
 
 
1.11 Pathogenesis of camel trypanosomiasis 
 
The Trypanosoma evansi infection is characterized by   emaciation and 
anaemia which is macrocytic (Jatker and Singh, 1971). Haematologically 
there is a reduction in Haemoglobin (HB) and PCV as well as level of Ca, K, 
Na and CI.(Elazahri, 1962; Raisinghani et al., 1981). The infection is 
accompanied by progressive change in the serum protein concentration, with 
an 1gM level increase during the infection (Boid et al., 1985). The same 
author stated that also serum enzymes increase namely sorbital 
dehydrogenase and glutamate pyruvate transaminase . Darosa (2000) found 
an increase of albumin, creatinine, uric acid, and urea in urine of infected 
camels with T. evansi compared to non-infected controls. He recommended 
that an investigation is needed on whether this odour change of urine is 
particular for camel infected with T. evansi as compared to other animal 
species and other trypanosomes infections. 
 
 
 
 
 
1.12 Diagnosis of camel trypanosomiasis 
 
1.12.1 Parasitological examinations 
 
Diagnosis of trypanosomiasis is only confirmed if the parasite can be 
demonstrated in peripheral blood. Wet blood films and Giemsa’s stained 
blood smears are satisfactory for detection of acute infection, but inefficient 
in case of chronic forms (Luckins et al., 1979). A wet blood film is 
considered to be sensitive, but it may not be reliable when the parasitaemia 
is low (Rae et al., 1989). The thick blood film is simple and inexpensive, it 
is sometimes possible to identify the trypanosomes species seen, however, 
the sensitivity of thick blood film is limited as well as an immediate 
diagnosis of trypanosomiasis on the spot is not possible. 
 
The concentration methods include the dark ground phase contrast buffy 
coat methods (DG) and haematocrit centrifugation technique (HCT) (Woo, 
1970) the buffy coat/plasma interface is examined under 10×40 objective, if 
possible using phase contrast and dark field illumination. Trypanosomes are 
found wriggling at the junction of the plasma and buffy coat layer (Murray, 
et al., 1977). 
 
Diethyl aminoethyl cellulose adsorption (DEAE cellulose) (Lanham and 
Godfrey, 1970) uses anion exchange column to separate the trypanosomes 
from the cellular elements in blood. Heparinzed blood is passed through a 
DEAE cellulose colurmn equilibrated against a buffer solution specific for 
the blood of the animal under examination. Since the erythrocytes are more 
negatively charged than trypanosomes, the latter pass in the ellute , which is 
then centrifuged to concentrate the organisms for microscopical 
examination. Originally the technique was used as a means of obtaining 
trypanosomes free from other elements than as a diagnostic tool, however, 
Lumsden et. al. (1979) modified the method to be adapted to field use. 
 
1.12.2 Biological examinations 
 
Inoculation of animals especially rodents was of some diagnostic value, but 
laboratory animals are often not available in endemic areas and this method 
is therefore not used regularly in the field (Luckin et. al.,1979). Elmalik 
(1976) stressed that inoculation of experimental animals as a diagnostic 
procedure was of limited value due to the presence of some refractory 
species or strains  of trypanosomes, difficulty of keeping of laboratory 
animals under field condition and the period of time required for getting 
results.  
 
1.12.3 Biochemical tests 
 
A number of chemical tests for T. evansi infection depended on increased 
serum globulin content had been described.  These include the mercuric 
chloride test (MCT) (Bennett, and Kenny 1929), the formal gel test (FGT) 
(Planturex, 1928). These methods were not specific for trypanosomiasis and 
were not sufficiently reliable for accurate diagnosis (Elmalik, 1976 and 
Oshake, 1988). 
 
1.12.4 Serological examinations 
 
Serological methods assessing levels of circulating antigens and /or 
antibodies included  Immuno-fluorescent antibody test (IFAT) (Zwart et al., 
1973), Enzyme linked  immunosorbant (ELISA) (Voller et al., 1976),  
indirect haemagglutination test (Gill, 1966) and complement fixation test 
(CFT) (Schoening, 1924). 
 
Suratex is a sensitive latex agglutination test for diagnosis of infection 
caused by trypanosoma evansi in camels. It is used for diagnosis of both 
patent and sub-patent infections. The sub-patent infection are usually 
chronic and they constitute more than half of the infections in the field. 
These infections are difficult to diagnose by other means  (Nantulya, 1994, 
Olaho-Mukani et al. 1996;  Elsaid et. al., 1998). The Card Agglutination 
Test (CATT) based on the presence of widely distributed variable surface 
antigen (Bajyana-Songa et al., 1987). 
 
1.12.5 Polymerase chain reaction (PCR) 
 
This test now available for use in the identification and diagnosis of 
trypanosomatids in their hosts and vectors (Hide, 1997) and provides the 
opportunity to examine the parasite specific gene expression, transmission 
and development through the insect vector. 
 
PCR is based on the use of an enzyme, DNA polymerase, which amplifies 
sequences of DNA bases, until sufficient material is produced to be detected, 
It does so by polymerization of nucleic acids. Important advantages of PCR 
over DNA probes are the greater sensitivity and the fact that no radioactive 
isotopes are needed. There are also many disadvantages, where false 
negative results may for instance be obtained if the specificity of the primers 
is too high, e.g. many infections by T.vivax are not recognized by existing 
primers.Another reason for false negative results is that whole blood 
contains factors which inhibit the PCR (FAO, 1998). 
 
1.13 Isoenzymes characterization of Trypanosoma evansi isolates 
 
Enzymes electrophoresis has been widely used in characterization of 
parasitic and non-parasitic protozoa, e.g. trypanosomes (Gibson, et al., 
1978). Isoenzyme analysis of trypansomes is a useful technique for 
characterization of T. evansi and for its differentiation from T. b. brucei. 
Gibsan et al. (1980) found a correlation between members of trypanozoon 
subgenus on the basis of isoenzymes characteristics. Gibson and Cashumba 
(1983) found that most of T. evansi from Northern Kenya were closely 
similar to the reference stocks from Nigeria and Sudan. The first relationship 
between isoezymes and drug resistant phenomenon was well documented by 
Boid et al. (1989), who stated that type VII isoenzyme of Malik enzyme is 
an indicator of a high level of Suramin resistance in T. evansi. 
 
1.14 Pulsed field gel Electrophoresis 
 
Gel electrophoresis is one of the most commonly used for DNA fragments 
separation techniques as well as its use in the purification and separation of 
proteins and nucleic acids. Van der Pleog et al (1984) studied the molecular 
karyotype of kinetoplastid parasites and observed significant differences 
between trypanosome species. It was reported that stocks of T. evansi from 
different geographical locations   showed limited heterogeneity in 
isoenzymes (Gibson et al., 1983; Boid, 1988), KDNA minicricle sequences 
(Borst et al, 1987), and variable antigen type repertoires (Bajyana Songa and 
Harmers, 1987). The analysis of minicricles seems to be the most reliable 
method. for differentiating between T. evansi and T. brucei (Borst and 
Hoeijmakers, 1979; Borst et. al. 1987). Waitumbi and Young (1994) found 
that distinguishing T. evansi isolates by molecular electrophoretic 
karyotypes is more discrete than KDNA and the different karyotype patterns 
can be used to identify parasites from distinct origins in field studies. 
 
 
 
 
1.15 Cultivation of Trypanosoma evansi 
 
The first major success in the production of the blood stream trypanosomes 
form in culture was made with T. brucei by Hirumi et al. (1977), who 
produced blood steam form of T. brucei in the presence of serum and a 
feeder layer of a mammalian fibroblast like cells. 
 
Attempts were made to culture T. evansi in low temperature (28°C) culture 
system in the tsetse tissues, a system in which T. brucei parasites  
transformed rapidly to uniform population of procyclic trypanosomes 
(Mahmoud and Cunningham, 1981). A number of researchers succeeded to 
maintain T. evansi as blood stream forms at 37°C over monolayers of 
various cells in the presence of 20% V/V heat-inactivated horse serum 
(Zweygarth et al., 1982, 1983; Zweygarth and  RÖttcher, 1986). Asian  
isolates were eaiser to cultivate than African stocks (Zweygarth and 
RÖttcher, 1986; Brun and Lun, 1994). Further observation revealed that 
extended cultivation of an African stocks of T. evansi led to the appearance 
of dyskinetoplastic trypansomes, which had a lower infectivity for mice 
(Zweygarth et al., 1991). Zweygarth and Kaminsky (1989) described a 
simple culture system in which all T. b. brucei stocks transformed to the 
procyclic form at 22°C  but in which the T. evansi stocks tested did not 
survive beyond 5 days of cultivation.  
 
1.16 Control  of camel trypanosomiasis 
 
Control of all forms of trypanosomiasis can be achieved either through 
control of the causal agent or control the vector.  
The major constraint to develop a commercially applicable vaccine is the 
phenomenon of antigenic variation with multiplicity of antigens involved. 
Hence, trypanocidal drugs are still regarded as a main factor in control of the 
disease. 
 
Chemotherapy is the treatment of disease by the use of chemical agents. 
Such  drugs are curative, they disturb or block one ore more of the vital 
processes which are essential to the invading micro-organism. While, 
chemoprophylaxis or chemoprevention is the prevention of disease by the 
use of chemical drugs. Logically, this implies a residual effect, as prevention 
depends on the persistence of the drug in the system of the animal. A 
chemoprophylactic drug is also curative, but a curative drug is not 
necessarily prophylactic. Curative drugs are mainly used where disease 
incidence is low and only limited number of animals in a herd contract the 
disease during the course of a year. Prophylactic drugs are used where the 
risk is so high that the health of the herds can not be maintained by 
individual application of curative compounds. 
 
Trypanocides which have been used extensively in veterinary medicine 
include Suramin (Nagnol, Antrypol), Qinapyramine sulphate (Antrycide, 
Trypcide, Quintrycide), Homidium (Ethidium, Prothidium), Diminazene 
aceturate (Berenil), Isometamidium chloride (Samorin, Trypamidium) and 
mel cy (Cymelarsan) (Table 1).   
  
For control of mechanical vectors of trypanosomiasis, tabanid flies were 
captured in a sheep pasture in Hungary (Hall et al., 1998) using black plastic 
boards coated with an a adhesive sheet, which were either unbaited or baited 
with ethane-ethiol or swormlure 4. The authors observed that males were 
significantly more numerous, probably due to a repellent effect of the odours 
on female tabanids. A study of the distribution of larvae of Tabanus 
nigrovittatus in relation to the presence or absence of surface water showed 
that larval densities were higher in salt marsh areas that appeared well 
drained. Biological control of house flies and somoxys calcitrans has been 
evaluated by Skovgard and Nachman (2004). The result revealed that a 
significant suppression of house fly populations to below nuisance level took 
place, whereas no effect on stable flies was found. 
 
1.17 Drug resistance 
Drug resistance can be defined as a loss of sensitivity by a strain of an 
organism to a compound to which it had previously been susceptible. It 
implies failure of treatment or prevention (FAO, 1998). 
 
Resistance in trypanosomes has been induced through exposure to sub-
curative doses whilst in the field, under dosing could be a contributing factor 
to the development of drug resistance. There are several ways in which 
under dosing can occur in the field. These include: 
 
1. When the drugs are administered by unqualified personnel in the 
absence of proper diagnosis. 
2. Treating animals on the basis of average rather than individual weight 
resulting in some animals being under dosed. 
3. Keeping animals on prophylactic treatment in high challenge or 
endemic area for long periods of times. 
Table 1: Commercial trypanocides* (Source: FAO, 1998) 
Generic name Trade names 
** 
Solution 
for use 
Dosage 
rate *** 
Route Remarks 
Suramin Naganol 10% 10mg/kg 
(1ml/10kg) 
IV Mainly used 
against T. evansi 
in camels 
Diminazene 
aceturate 
Berenil, 
Ganaseg, 
Trypazen, 
7% 3.5-7 
mg/kg (1-2 
ml/20kg) 
IM Mainly used in 
cattle and small 
ruminants. Should 
Veriben be dissolved in hot 
water. Potentially 
carcinogenic 
Homidium 
chloride 
Ethidium C, 
novidium 
2.5% 1 mg/kg 
(1ml/25 
kg) 
IM See above, but 
soluble in cold 
water 
Quinapyramine 
methyl 
sulphate 
Antrycide, 
trypacide, 
noroquin, 
Quintrycide 
10% 5 mg/kg (1 
ml/20kg) 
SC Now mainly used 
against T.evansi 
and T.brucei in 
camels and horses  
Melcy Cymelarsan 0.5% 0.25-0.5 
mg/kg (1-2 
ml/20 kg) 
IM or 
SC 
Registered only 
for use against 
T.evansi in camels 
Isometamidium 
chloride 
Samorin, 
Trypamidium
1% 
 
2% 
0.25-0.5 
mg/kg 
(1.25-25 
ml/50 kg) 
(2.5 ml/50 
kg) 
IM Used mainly in 
cattle, as curative 
at lower rates, as a 
prophylactic at 
higher rates. Also 
contains 
homidium, and is 
therefore to be 
considered as 
potentially 
carcinogenic as 
well   
* Not all of these trypanocides may be available in every country and there is also 
no guarantee that production of all of them will be continued. The situation is 
rather fluctuating, mainly because of economical reasons. 
**  The list of trade names is not complete, and names listed do not imply a 
qualitative judgement 
 *** Dosage rate of solution for use are given in brackets.  
Osman et al. (1992) studied the effects of immunosuppression on the 
development of drug resistance by trypanosomes in mice infected with 
various clones of T. evansi. Their results demonstrated the rapid 
development of high levels of resistance to Melasenoxide, Cysteamine, 
Diminazene and Isometamidium in the clones following frequent passage in 
immunosuppressed mice given sub-curative drug treatments. However, drug 
resistance did not develop when frequent passage was undertaken in normal 
immunocompetent mice infected with the same clones of T. evansi. Their 
results suggested that impairment of the host immune system may lead to 
rapid development of resistance. 
 
Trypanosomes population resistant to one trypanocidal drug compound and  
have been found to be resistant to other active trypanocidal drug compounds, 
are called cross-resistant (Whiteside, 1962). Relapses of T. evansi infections 
were reported soon after Suramin was introduced for wide scale use in the 
field (Knowles, 1927). Suramin-resistant strains of T. evansi were reported 
from Sudan, India, Russia and Indonesia (Boid et a.l, 1989; El Rayah, 1997), 
Kuwait (Al Taqi, 1989), and China (Fang et al., 1994). Suramin-resistance 
can be induced in the laboratory (Gill, 1971; Fang et al., 1994). Strains of T. 
evansi resitant to both Suramin and Quinapyramine were isolated from 
camels (Schillinger and RÖttcher, 1984). 
 
In order to delay the development of resistance, the following are 
recommended by FAO (1998): 
 1. Avoid under dosing. 
2. Reduce the application of trypanocidals by integrating their use with 
other control methods. 
3. Systemic mass treatments exert a strong selection pressure for 
resistance. 
 
1.18 In-vivo assessment of drug sensitivity 
 
In-vivo tests were conducted by workers in camels (Petrovisky, 1974; Ali et 
al., 1986). Dukes et al. (1991) explained that mice are very sensitive for 
Trypanosoma evansi. The mouse test is still considered as the standard test 
for assessment of drug sensitivity. 
 
 
1.19 In-vitro assays with out in-vitro adaptation 
 
In-vitro assays which do not require pre-adaptation to culture are those 
exposure to drug in cell culture is for a relatively short time, and the criterion 
is cell viability and not growth of trypanosomes. These included Drug 
Incubation Infectivity Test (DIIT) (Kaminsky et al., 1990) and [H3]-
Hypoxanthine Incorporation Assays (Brun and Lun, 1994). 
 
1.20 Assays which require In-vitro Adaptation 
 
These assays included: Photomeric Assay (Zinsstag et al., 1991; Kaminsky 
and Wasike, 1992), Flourescence Assay (Obexer et al., 1994), Growth 
Inhibition Assay (Kaminsky and Zweygarth, 1989; Zhang et al., 1992), and 
Long-Term Viability Assay (Kaminsky et al., 1989; Brun and Lun, 1994). 
 
 
 
 
 
 
CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1 Study area 
 
The study was conducted in three Districts namely Butana, Gadarif and 
Southern Kordofan. These areas are regarded as the most important sites for 
camel rearing in pastoral production system of Sudan (Figure 1). 
 
Butana and Gadarif district lie between latitudes 12 - 16° N,  on a strech of  
clay soil and an average annual rainfall of about 581 mm and it may 
decrease to 76 mm during draught. Vegetation is mainly composed of 
grasses e.g. Schoenfeldia gracialis, Aristidia mutablis, Ipomoea 
carolosepala, and Indigofera hochstelleri. The main tribes keeping camel 
are Kwahla, Lahawien, and Shukria. During the rainy season camels are 
grazed at Butana plain in natural grazing pasture and they migrate to Gadarif 
State in dry season (Abbas and Musa, 1988; Darosa, 2000). 
 
Southern Kordofan district is located between latitudes 9 - 13° N. Mountains 
are scattered all over the district. The rainfall reaches up to 600 mm and the  
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vegetation of the area is composed of trees and grasses of different densities. 
The main tribes keeping camels are Shenabla and Bin Jrar. They spend the 
rainy season in Northern Kordofan and White Nile district and they move 
back again to Southern Kordofan in the dry season  (Ibtisam, 2004). 
 
 
2.2 Study population 
 
The target animals that were investigated are from herds of the traditionally 
managed dromedary camels (Camelius dromedarius). Only camels with 
trypanosomiasis were sampled regardless of the age, sex, breed, and season. 
The history of each case was taken and the clinical manifestations recorded.  
 
2 . 3  S a m p l i n g  s t r a t e g i e s  
 
According to the avialability of the camel herds as well as willingness of the 
owner, non-probability sampling method (convenience sampling) was 
employed in the study site as described by Thrusfiel (1996). A total of 13 
isolates of T. evansi (7 from Butana, 2 from Gadarif and 4 from Southern 
Kordfan) were collected. 
 
2.4 Parasitological examination using Wet mount 
 
 
One drop of blood from ear vein of sick or suspected camel with 
trypanosomiasis was placed on clean slide and covered with a cover slip, 
examined under microscope at a magnification 10×40. Positive samples 
were taken for further use. 
  
2.5 Propagation of T . evansi isolates in laboratory rodents 
 
About 3 ml of blood was collected from the jugular vein of camels with 
trayanosomiasis using vacutainer with EDTA after confirmation by wet 
mount. Initial propagation of trypanosomes was done in albino white mice. 
Each mouse was injected intraperitoneally with 0.5 ml of the trypanosome 
positive camel blood. 
 
2.6 Cryopreservation of T . evansi isolates in liquid nitrogen 
 
Tail blood of the inoculated mice was monitored for Parasitaemia daily by 
using wet mount. At peak parasitaemia trypanosomes were harvested by 
cardiac puncture. About 0.85 ml of blood with trypanosomes was added to 
the 0.85 ml of phosphate-buffered saline glucose (PSG) containing 20% 
glycerol into kryo-tube (2 ml) and then transferred through gradual cooling 
to liquid nitrogen (-196°C) (in the phase of liquid nitrogen). 
 
2.7 Experimental design 
 
Each isolates of T. evansi was tested for drug resistance against 
Quinapyramine and Cymelarsan. For that purpose albino mice were used as 
described by Eisler (2001) (Table 3). 
 
1- Control group  
 
Positive control: Each isolates of T. evansi from each district was 
inoculated intraperitoneal in 6 albino mice and observed for two 
months without drug administration. 
 
2- Experimental group 
 
    Each isolates of T. evansi from each district was inoculated 
intraperitoneally in 6 albino mice and then tested for drug 
resistance against Quinapyramine and Cymelarsan, the drugs 
were given S/C. The mice were monitored over two months. A 
trypanosome isolate was considered as drug-sensitive if at least 
5 out of the 6 treated mice were cured. If fewer than 5 mice 
were cured, the isolate was considered resistant to the dosage 
used (Eisler, 2001).  
 
2.8 Polymerase Chain Reaction (PCR) 
 
Extraction of DNA from blood samples 
 
Whole blood was used for extraction of total genomic DNA using 
commercially available QIAamp blood kit according to the manufacture΄s 
instruction. Extraction of DNA from blood samples was done as following: 
 
1. Twenty µl of proteinase k was piptted into the bottom of 1.5 ml 
microcentrifuge tube. 
2. Two hundred  µl of blood sample was added to the microcentrifuge 
tube. 
3. Two hundred µl of buffer Al was added to the sample and mixed for 
15 second. 
Table 2: Standardized protocols for testing trypanocidal drug resistance in mice 
(Source: Eisler, 2001) 
 
 
IP: intraperitoneal  
Single-dose test refer to the isolates from the same geographical area while Multi-dose 
test to the individual isolate. 
a Mice should be weighed to an accuracy of I g and body weights should not vary by 
more than 10%; strain, sex and age of mice should be recorded. 
 
 
                                 Unit 
  
 Single test in micea                     Multi–dose test in 
micea                    
                    
 
Number of groups of animals Treatment  gropes per 
drug 
 Control groups 
Number of animals / group Inoculums   
N  umber of trypanosomes                                
 Route of administration                                               
 Time drug administration  
 
Parasitological examination 
     Method   
     Frequency   
Duration of follow- up (days )  
 
I nterpretation  of results for treated animals  
      Isolate sensitive   
 
      Isolate resistantf                                  
 
        1                                                            5 
            1                                                             1      
            6                                                             6  
           10 5                                                        105 
        IP                                                          IP 
24 h post- inoculation                    24 h post- inoculation 
 
 
Tail blood wet smear                     Tail blood wet smear    
Two times per week                      Two times per week      
          60                                                         60 
 
    
     At least 5/6 cured                   Probit or logit   analysis      
                                                            of number of mice  
                                                            cured  at  each dose   
     At least 5/6 not cured                                                         
4. The sample was incubated at 56 ºC for 10 minutes. 
5. Microcentrifuge tube was briefly centrifuged to remove droops from 
the inside of the lid. 
6. Two hundred µl of ethanol (96-100%) was added to the sample and 
mixed for 15 second. Then the 1.5 ml microcentrifuge was 
centrifuged briefly to remove droops from the inside of the lid. 
7. The mixure was applied to the QIAamp Spin Column in a 2 ml 
collection tube. The cap was closed and centrifuged at 1 minute. The 
QIAamp Spin Column was placed in a clean 2 ml collection tube and 
the tube containing filtrate was discarded. 
8. The QIAamp Spin Column was opened and 500  µl buffer Aw1 was 
added. The cap was closed  and centrifuged for 1 minte. The QIAamp 
Spin Column was placed in a clean 2 ml collection tube. The 
collection tube containing the filtrate was discarded. 
9. The QIAamp Spin Column was opened and 500  µl buffer Aw2 was 
added. The cap was closed and centrifuged for 3 minutes. 
10. The QIAamp Spin Column was placed in a clean 1.5 ml 
microcentrifuge tube, 200  µl AE was added and incubated at room 
temperature for 1 minute and centrifuged for 1 minute. 
 
Polmerase Chain Reaction (PCR)  
 
The DNA (5  µl) was added to 17.5  µl mixture, 2  µl primers and 0.5 µl 
polymerase (Taq). Then the mixture was centrifuged for 1 minute. Then the 
PCR was running for 2 hours at 56 ºC. PCR containing amplified products 
were loaded onto gels of Seakem agarose and electrophoresed gels were 
stained with ethidium bromide and T. evansi primary PCR products were 
easily identified following visualization under UV light.  
 
 
 
 
 
 
 
 
 
 
 
 
CHPTER THREE 
RESULTS 
 
 
For Quinapyramine sulphate 36 mice (6 control and 6 tested group for each 
state) were used (the drug was given S/C), the result revealed that the 
isolates were very sensitive in Southern Kordofan state (6 mice were cured). 
However, the isolates had shown resistance in all mice infected with Butana 
and Gadarif state isolates (Table 3,4,5).The results of all states showed that 
out 36 mice tested (18 mice tested group and 18 mice control group) only 6 
mice were cured and 12 mice were not cured with Quinapyramine sulphate 
(Table 6). Regarding Cymelarsan, 36 mice (6 control and 6 tested group for 
each state) were used (the drug was given S/C), the result showed that the 
drug was very curative in Southern Kordofan and Gadarif state (all mice 
were cured), but the isolates had shown some degree of resistance (4 out of 6 
mice were cured) in Butana state (Table 3,4,5). The results of all states 
showed that out of 36 mice tested (18 mice tested group and 18 mice control 
group) 16 mice were cured and only two mice were not cured with 
Cymelarsan (Table 6). 
 
Eighteen  mice infected with T. evansi died (6 mice for each state) when the 
Quinapyramine sulphate was given intapretoneally. Double dose was used 
for assessing drug resistance against Quinapyramine on 36 mice (6 control 
and 6 tested group for each state) infected with T. evansi from Butana, 
Gadarif and Southern Kordofan state, the result revealed that 18 mice (6 
mice for each state) were killed, the result was given in Table 7. 
 
Polymerase Chain Reaction (PCR) was used on 13 isolates of T. evansi from 
Butana, Gadarif and Southern Kordofan state, the result showed that PCR 
was very sensitive in detecting differences in Butana and Gadarif state. All 
isolates were similar. As to the isolates which were tested by PCR in Butana 
and Gadarif states, 9 of them were resistant to Quinapyramine sulphate and 7 
isolates were sensitive to Cymelarsan. One isolate out of 4 isolates tested by 
PCR in Southern Kordofan state was different (the isolate was sensitive to 
both Quinapyramine sulphate and Cymelarsan (Figure 2,3,4). 
 
 
 
 
 
Table 3: Testing Trypanosoma evansi in mice for drug resistance in 
Butana state 
 
 
 
Drug 
 
No. of 
isolates 
tested 
 
No. of 
mice in 
control 
group 
 
No. of 
mice in 
tested 
group 
 
No of 
mice 
cured 
 
 
Interpretation 
 
Quinapyramine 
sulphate 
 
7 
 
6 
 
6 
 
- 
0.00% 
 
Drug- 
resistant 
 
Cymelarsan 
 
 
7 
 
6 
 
6 
 
4 
66.67% 
 
Drug- 
resistant 
 
 
 
 
 
 
 
Table 4: Testing Trypanosoma evansi in mice for drug resistance in 
Gadarif state 
 
 
 
Drug 
 
No. of 
isolates 
tested 
 
No. of 
mice in 
control 
group 
 
No. of 
mice in 
tested 
group 
 
No of 
mice 
cured 
 
 
Interpretation 
 
Quinapyramine 
sulphate 
 
2 
 
6 
 
6 
 
- 
0.00% 
 
Drug- 
resistant 
 
Cymelarsan 
 
 
2 
 
6 
 
6 
 
6 
100.00% 
 
Drug- 
sensitive 
 
 
 
 
 
 
 
Table 5: Testing Trypanosoma evansi in mice for drug resistance in 
Southern Kordofan state 
 
 
 
Drug 
 
No. of 
isolates 
tested 
 
No. of 
mice in 
control 
group 
 
No. of 
mice in 
tested 
group 
 
No of 
mice 
cured 
 
 
Interpretation 
 
Quinapyramine 
sulphate 
 
4 
 
6 
 
6 
 
6 
100.00% 
 
Drug- 
sensitive 
 
Cymelarsan 
 
 
4 
 
6 
 
6 
 
6 
100.00% 
 
Drug- 
sensitive 
 
 
 
 
 
 
 
Table 6: Testing Trypanosoma evansi in mice for drug resistance in 
Butana, Gadarif and Southern Kordofan state 
 
 
 
Drug 
 
No. of 
isolates 
tested 
 
No. of 
mice in 
control 
group 
 
No. of 
mice in 
tested 
group 
 
No of 
mice 
cured 
 
 
Interpretation 
 
Quinapyramine 
sulphate 
 
13 
 
18 
 
18 
 
6 
33.33% 
 
Drug- 
resistance 
 
Cymelarsan 
 
 
13 
 
18 
 
18 
 
16 
88.89% 
 
Drug- 
sensitive 
 
 
 
 
 
 
 
Table 7: Testing T. evansi in infected mice for double dose for drug 
resistance against Quinapyramine sulphate in Butana, Gadarif and 
Southern Kordofan state 
 
 
 
State 
 
No. of 
isolates 
tested 
 
No. of 
mice in 
control 
group 
 
No. of 
mice in 
tested 
group 
 
No of dead 
mice 
 
Butana 
 
 
7 
 
6 
 
6 
 
6 
100.00% 
 
Gadarif 
 
 
2 
 
6 
 
6 
 
6 
100.00% 
 
Southern 
Kordofan 
 
 
4 
 
 
6 
 
6 
 
6 
100.00% 
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             Figure 2: Trypanosoma evansi from Butana state 
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                     Figure 3: Trypanosoma evansi from Butana state 
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                    (The isolate number 3 was different compared to others) 
 
 
Figure 4: Trypanosoma evansi from Southern Kordofan state 
 
 
 
CHAPTER FOUR 
DISCUSSION 
 
Trypanosoma evansi, the cause of trypanosomiasis (Surra) constitutes one of 
the major veterinary problems worldwide. The disease causes significant 
morbidity and mortality in camels in Sudan. Drug resistance in 
trypanosomiasis can be defined as the ability of trypanosome strains to 
survive, despite of administration of drug given in doses equal to or higher 
than those usually recommended. Drug resistance is one of the very 
important explanations for the failure of treatment with trypanocidals in the 
field. For a more efficient and economic control of camel trypanosomiasis 
by means of chemotherapy a better surveillance for the drug resistance is 
required. 
 
In this study, Quinapyramine sulphate has shown resistance in Butana and 
Gadarif state. Quinapyramine sulphate is the drug of choice used nowadays 
for the treatment of camel trypanosomiasis in the Sudan. Expired 
preparations and sub-curative doses as well as bad administration of the drug 
were used by camel owners who have special preference to this preparation. 
Consequently over this long period of extensive usage various population of 
T. evansi had been exposed to this drug. This situation provided ideal 
condition for the development of aquired trypanocidal drug resistance. 
Quinapyramine sulphate has been reported to be a drug of choice for the 
treatment of Suramin-resistant T. evansi in camels (Finelle, 1973; Curd and 
Davey, 1950; Leach, 1961; Gill and Malhotra, 1971; Luckins et al., 1979). 
Our results confirm the previous observation of emergence of strains 
resistant to routine treatment with Quinapyramine sulphate (Luckins et al., 
1079; Mahmoud and Osman, 1979; Schillinger et al., 1984; El Rayah and El 
Malik, 1990, El Rayah, 1997). Another study by Khier and Abdalla (1983), 
showed that stocks were only sensitive to Quinapyramine sulphate at doses 
higher than the normal prescribed doses. El Rayah (1990) explained that 
further development of resistance to Antrycide can only be avoided if the 
dose, number of doses or treatment intervals are manipulated. She 
demonstrated that the successful treatment can be achieved by two 
successive single doses administered at a 2-day interval. However, 
investigations on the pharmakinetics of the drug in camel are necessary to 
provide evidence in support of these speculations. In order to understand 
drug resistance in Chinese Trypanosoma evansi to Suramin and Antrycide 
by Jinlin et al. (2004), in-vivo experiment in mice with selected isolates 
showed resistant to Suramin was not cured at a dose rate of 5 mg/kg. While, 
the isolate that was most resistant showed only 50% cure rate at a dose rate 
of 5 mg/kg. His data indicated that T. evansi in China had differences in 
drug resistance, with some isolates exhibiting low sensitivity while a few 
isolates showed complete drug resistance to curative dosages of Suramin or 
Antrycide. He also observed cross resistance between Suramin and 
Antrycide. 
 
Beween the 1950s and 1970s Quinayramine sulphate was widely used in 
Africa as a therapeutic and prophylactic agent in cattle (Fiennes, 1953; 
Ruchel, 1975). Resistance to this compound appeared to develop rapidly 
(Unsworth, 1954; Wilson, 1949) and was often associated with concomitant 
cross-resistance to Isometamidium, Homidium and Diminazene (Mwambu 
and Mayende, 1971; Whiteside, 1960). However, it was impossible to 
ascertain whether the apparent cross-resistance actually was cross-resistance 
or reflected difficulties in interpreting field-derived data. In 1976 
Quinapyramine ceased to be manufactured (Holmes and Scott, 1982) 
because of the ease with which resistance appeared to develop (Fiennes, 
1953; Leach and Roberts, 1981; Newton, 1964) and because of problems 
with drug toxicity (Davey, 1957). However, in 1984 the compound was 
reintroduced to the market, but only for use in camels (Schillinger and 
Rottcher, 1986). The cross-resistance phenotypes of trypanosomes 
populations selected for resistance to Quinapyramine, reported by different 
authors, have varied. A Quinapyramine-resistant T. equiperdum population 
produced by Ormerod (1952) expressed a high level of cross-resistance to 
Dimidium and Stilbamidine. Similarly, a Quinapyramine-resistant stock of 
T. conglense generated by Hawking (1963) was shown to be cross-resistant 
to Diminazene. However, while a similar population of T. evansi was cross-
resistant to Metamidium ( a mixture of isomers, one of which was 
Isometamidium (Wragg et al., 1958), the same population exhibited no 
cross-resistance to either Stilbmidine or organic arsenical tryparsamide (Gill, 
1971). Cross-resistance is resistance to a drug that has arisen as a result of 
previous exposure of the trypanosome strain to a different drug. Cross-
resistance drugs are often members of the same chemical family. The 
resistance that appears to the drug used is known as primary resistance, that 
which appears to a different compound is called secondary resistance (FAO, 
1998). 
 
Our study revealed that T. evansi subjected to Cymelarsan at a dose rate of  
0.25 mg/kg was very sensitive in Southern Kordofan and Gadarif state. 
However, the parasite had shown some degree of resistance in Butana. This 
is an arsenical drug, related to Melarsen (Which is used in human sleeping 
sickness). The name mel cy is derived from the che mical formula Melarsen 
oxide, with cysteamine as a lateral chain. It dispensed as a drug powder, 
highly soluble in water. The drug was develop in the 1980s for use against 
Surra (T. evansi infection) in camels, as the other compounds in use against 
this disease are either frequently associated with resistance problems to 
Suramin and Quinapyramine (Luckins, 1998; Bourdichon, 1998). It has also 
been tested against T. evansi in domestic buffaloes and T. evansi and T. 
brucei in other animals (FAO, 1998). Treatment of T. evansi infected camel 
in Morocco with Cymelarsan reduced sero-prevalence level from 58 to 19% 
within a year (Rami et al., 2003). However, relapses in camels after 
treatment have been reported (Otsyula et al., 1992).  
 
In order to delay the development of resistance (complete avoidance of its 
development is probably impossible), the following are recommended by 
avoiding under dosing, incorporate integrated trypanocidal and systemic 
mass treatment control. 
 
The same report indicated that when resistance first appears in the course of 
drug regime it is confined to the parasites present in relatively small 
numbers of animals, but numbers will increase rapidly, particularly if it is 
not detected and sub-curative level persisted or increased. The trypanosomes 
become more and more efficient at dealing with the trypanocide and each 
retreatment  will lead to an increased level of resistance. 
 
In this study Polymarse Chain Reaction (PCR) was very sensitive in 
detection of T. evansi infection in camels. Several methods had been 
developed for the detection of T. evansi infection including microscopy, card 
agglutination test (CATT) (Guterrez et al., 2000), microhematocrit 
centrifugation technique (MHCT) (Woo, 1970), enzyme-linked 
immunosorbent assay (ELIZA) (Indrakamhang et al., 1982), DNA 
hybridization (Viseshakul and Panyim, 1990) and polymarse chain reaction 
(PCR) (Wuyts et al. 1994; Wuyts et al., 1995; Omawa et al., 1999). The 
PCR provided high sensitivity among these methods and it had been 
reported that it could detect T. evansi three days earlier than by microscopy 
(Ijaz et al., 1998). A study by Wasana et al. (2000) had shown that PCR-
based assay is one of the most powerful tools for the detection of T. evansi 
in several animals and vectors. Based on that it will be beneficial for 
epidemiological studies of this parasite and for the control program. In 
Sudan, Ardaib and Majid (2006) indicated  that nested polymarse chain 
reaction (nPCR)-based assay, using well characterized T. evansi primers, 
provides a simple, rapid, sensitive and specific detection of T. evansi in 
naturally infected camels (Camelus dromedaries) and can be as a valuable 
tool during epidemiological surveys and control program.    
 
In conclusion camel trypanosomiasis has been recognized as the most 
important single cause of economic losses in camel rearing areas, yet there 
have been no planned campaigns to control T. evansi using modern methods 
of fly control or chemotherapy. In most cases, control is limited to treating 
those animals that are considered to be infected on the basis of unreliable 
clinical sign. On the other hand prolonged and regular use of a drug 
apparently inevitably leads in the end to the development of resistance by 
the parasite. 
 
Based on this study the following are recommended: 
 
1. For a more efficient and economic control of camel trypanosomiasis 
by means of chemotherapy a better surveillance for the drug resistance 
is required. 
2. Introduction of the new drug Cymelarsan and removal of 
Quinapyramine sulphate from the field will help in controlling the 
spread of drug resistance to Quinapyramine sulphate. 
3. Using PCR to demonstrate possible differences between resistant and 
sensitive isolates. 
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 ﻤﻠﺨﺹ ﺍﻻﻁﺭﻭﺤﺔ
 
 ﻓﺎﺭ ﺘﺠﺎﺭﺏ ﺍﺴﺘﻌﻤﻠﺕ ﻟﺩﺭﺍﺴﺔ ﻤﻘﺎﻭﻤﺔ ﺍﻻﺩﻭﻴﺔ ﻟﺩﻯ ﻤﺜﻘﺒﻴﺔ ٦٢١ﺤﻭﺍﻟﻲ 
ﺠﻤﻌﺕ ﻤﻥ ﻭﻻﻴﺎﺕ ﺍﻟﻘﻀﺎﺭﻑ ﻭﺍﻟﺒﻁﺎﻨﺔ ﻭﺠﻨﻭﺏ ﻜﺭﺩﻓﺎﻥ   ﻭﺍﻟﺘﻲ isnave amosonapyrTﺍﻟﺠﻤﺎل
 ٦٣ enimarypaniuQ  ﺒﺎﻟﻨﺴﺒﺔ ل .  nasralemyC ﻭ  etahplus enimarypaniuQﻀﺩ ﻋﻘﺎﺭ
ﻭﺘﻡ ﺍﻋﻁﺎﺀ ﺍﻟﻌﻘﺎﺭ (  ﻤﺠﻤﻭﻋﺔ ﺍﻟﻌﻼﺝ ﻟﻜل ﻭﻻﻴﺔ ٦ﺍﻟﺘﺤﻜﻡ ،  ﻤﺠﻤﻭﻋﺔ ٦)ﻓﺎﺭ ﺘﺠﺎﺭﺏ ﺍﺴﺘﻌﻤﻠﺕ  
 ﻓﺎﺭ ﺘﺠﺎﺭﺏ ﺘﻡ ٦)ﺘﺤﺕ ﺍﻟﺠﻠﺩ ﻭﺍﻟﻨﺘﻴﺠﺔ ﺍﻅﻬﺭﺕ ﺤﺴﺎﺴﻴﺔ ﻋﺎﻟﻴﺔ ﻟﻠﻤﺜﻘﺒﻴﺎﺕ ﻓﻲ ﻭﻻﻴﺔ ﺠﻨﻭﺏ ﻜﺭﺩﻓﺎﻥ 
ﺒﻴﻨﻤﺎ ﺍﻟﻤﺜﻘﺒﻴﺎﺕ ﻓﻲ ﻭﻻﻴﺔ ﺍﻟﻘﻀﺎﺭﻑ ﻭﺍﻟﺒﻁﺎﻨﺔ ﺍﻅﻬﺭﺕ ﻤﻘﺎﻭﻤﺔ ﻟﻠﻌﻘﺎﺭ ﻓﻲ ﻜل ﻓﺌﺭﺍﻥ ( ﻋﻼﺠﻬﺎ 
 ﻤﺠﻤﻭﻋﺔ ٦) ﻓﺎﺭ ﺘﺠﺎﺭﺏ ﺍﺴﺘﻌﻤﻠﺕ ٦٣  nasralemyC ﺎﺭ ﺒﺎﻟﻨﺴﺒﺔ ل ﻋﻘ .ﺍﻟﺘﺠﺎﺭﺏ ﺍﻟﺘﻲ ﺍﺴﺘﻌﻤﻠﺕ
ﺘﻡ ﺤﻘﻨﻪ ﺘﺤﺕ ﺍﻟﺠﻠﺩ ﻭﺍﻟﻨﺘﻴﺠﺔ ﺍﻅﻬﺭﺕ ﺤﺴﺎﺴﻴﺔ ﻋﺎﻟﻴﺔ (  ﻤﺠﻤﻭﻋﺔ ﻋﻼﺝ ﻟﻜل ﻭﻻﻴﺔ ٦ﺘﺤﻜﻡ  ، 
ﻟﻠﻤﺜﻘﺒﻴﺎﺕ ﻓﻲ ﻭﻻﻴﺔ ﺠﻨﻭﺏ ﻜﺭﺩﻓﺎﻥ ﻭﺍﻟﻘﻀﺎﺭﻑ ﻭﻟﻜﻥ ﺍﻟﻤﺜﻘﺒﻴﺎﺕ ﺍﻅﻬﺭﺕ ﺩﺭﺠﺔ ﻤﻥ ﺍﻟﻤﻘﺎﻭﻤﺔ ﻟﻠﻌﻘﺎﺭ 
  .ﻓﻲ ﺍﻟﺒﻁﺎﻨﺔ 
 
 amosonapyrT ﻓﺎﺭ ﺘﺠﺎﺭﺏ ﻤﺼﺎﺒﺔ ﺏ٨١ﺍﺩﻯ ﺍﻟﻰ ﻤﻭﺕ   etahplus enimarypaniuQ 
ﻋﻨﺩﻤﺎ ﺘﻤﺕ  ﻤﻀﺎﻋﻔﺔ . ﺒﺎﻟﺒﺭﻴﺘﻭﻥ  ﻋﻨﺩﻤﺎ ﺘﻡ ﺤﻘﻥ ﺍﻟﻌﻘﺎﺭ(  ﻓﺌﺭﺍﻥ ﺘﺠﺎﺭﺏ ﻟﻜل ﻭﻻﻴﺔ  ٦)   isnave
 ﻤﺠﻤﻭﻋﺔ ﻋﻼﺝ ﻟﻜل ٦ ﻤﺠﻤﻭﻋﺔ ﺘﺤﻜﻡ ﻭ ٦) ﻓﺎﺭ ﺘﺠﺎﺭﺏ ٦٣ﺍﻟﺠﺭﻋﺔ ﻟﻨﻔﺱ ﺍﻟﻌﻘﺎﺭ  ﺒﺎﻟﺤﻘﻥ ﻓﻲ 
  .ﺕ ﺍﻟﺜﻼﺙ  ﻓﺎﺭ ﺘﺠﺎﺭﺏ ﻓﻲ ﺍﻟﻭﻻﻴﺎ٨١ﺍﻅﻬﺭﺕ ﺍﻟﻨﺘﻴﺠﺔ ﻤﻭﺕ ( ﻭﻻﻴﺔ
 
 ﻤﺜﻘﺒﻴﺔ ﻤﻥ ﺍﻟﻭﻻﻴﺎﺕ ﺍﻟﺜﻼﺙ ﺍﻅﻬﺭﺕ ٣١ﻋﻠﻰ  (RCP )ﻋﻨﺩ ﺍﺴﺘﺨﺩﺍﻡ ﺘﻘﻨﻴﺔ ﺘﻔﺎﻋل ﺍﻟﺒﻭﻟﻴﻤﺭﺯ ﺍﻟﺘﺴﻠﺴﻠﻲ 
 ﻓﻲ ﻭﻻﻴﺘﻲ ﺍﻟﻘﻀﺎﺭﻑ ﻭﺍﻟﺒﻁﺎﻨﺔ ﺒﻴﻨﻤﺎ ﺍﻟﻤﺜﻘﺒﻴﺎﺕ ﻏﻴﺭ ﻤﺘﺸﺎﺒﻬﺔ ﻓﻲ   RCPﺍﻟﻨﺘﻴﺠﺔ ﺤﺴﺎﺴﻴﺔ ﻋﺎﻟﻴﺔ ل 
  .ﻭﻻﻴﺔ ﺠﻨﻭﺏ ﻜﺭﺩﻓﺎﻥ 
 
 
 
  
 
